Quick Answer
FILANA THERAPEUTICS, INC. reported Operating Income of -$95.39 million for fiscal year 2025.
FILANA THERAPEUTICS, INC. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$95.39M | +32.6% |
| 2024 | -$141.45M | -33.5% |
| 2023 | -$105.96M | -32.4% |
| 2022 | -$80.02M | -143.5% |
| 2021 | -$32.87M | -409.9% |
| 2020 | -$6.45M | -30.0% |
| 2019 | -$4.96M | +25.6% |
| 2018 | -$6.66M | +44.2% |
| 2017 | -$11.95M | +20.1% |
| 2016 | -$14.96M | -5.3% |
| 2015 | -$14.20M | -14.2% |
| 2014 | -$12.43M | -139.6% |
| 2013 | $31.36M | +904.8% |
| 2012 | -$3.90M | -10.9% |
| 2011 | -$3.51M | +74.4% |
| 2010 | -$13.70M | -102.9% |
| 2009 | -$6.75M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$11.86M | +61.3% | +73.9% |
| June 30, 2025 | -$45.39M | +26.1% | -84.6% |
| March 31, 2025 | -$24.59M | -23.3% | +19.7% |
| September 30, 2024 | -$30.62M | -9.8% | +50.1% |
| June 30, 2024 | -$61.40M | -113.4% | -208.0% |
| March 31, 2024 | -$19.93M | +24.8% | +28.5% |
| September 30, 2023 | -$27.88M | -30.6% | +3.1% |
| June 30, 2023 | -$28.78M | -44.5% | -8.5% |
- FILANA THERAPEUTICS, INC. showed an increase of +32.6% in Operating Income compared to the prior fiscal year.
- Over the 2009–2025 period, FILANA THERAPEUTICS, INC.’s operating income has declined by 1312.3% (from -$6.75 million to -$95.39 million).
- The most recent figure is from FILANA THERAPEUTICS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: